Congress Boosts FDA Food Safety Budget Nearly $700M, Orders Reports On Formula Supply
Executive Summary
Appropriators are “concerned by the fragility of the infant formula supply chain and the detrimental health impacts that can arise from shortage of these regulated products.” Their report published with FY2023 omnibus appropriations also asks for list of Russian firms with pending NDAs, including OTCs.
You may also be interested in...
In Proposed Appropriation, Congress Tells FDA To Repurpose $7M For Cosmetic Regulation
Proposed budget agreement by House and Senate leaders comes four days before funding ends under the latest continuing resolution to keep the federal government open and a week before the White House plans to release its FY2025 budget request.
House Members Take STAND On Tianeptine As ‘Unregulated Drug’ In Supplements
Reps. Panetta and Pfluger introduce Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act to make tianeptine a schedule III controlled substance a day after FDA posts latest alert to warn consumers against using products containing ingredient known as “gas station heroin.”
House Appropriations Subcommittee Proposes FDA FY2024 Budget $662M Short Of Request
Appropriations Agriculture, Rural Development, FDA and Related Agencies Subcommittee marked up its FY2024 bill on 18 May, proposing $6.579bn for FDA. Total is up from current budget of $6.562bn, but Biden administration proposed $7.2bn for FY2024.